Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Drug-induced hemolytic anemia is a condition where certain medications cause the destruction of red blood cells (hemolysis). While the diagnosis is typically made based on clinical symptoms, medication history, and blood count changes, specific blood tests are fundamental for identifying individuals at risk and understanding the underlying mechanisms.
This test measures the level of G6PD enzyme in red blood cells. Individuals with G6PD deficiency are at high risk for drug-induced hemolytic anemia when exposed to certain medications that cause oxidative stress. These drugs can trigger rapid destruction of red blood cells in G6PD-deficient individuals, making this test crucial for identifying at-risk patients before prescribing potentially harmful medications.
Some individuals have genetic enzyme deficiencies that make their red blood cells more susceptible to damage from certain medications. Blood testing is essential for identifying these predisposing factors before starting potentially triggering drugs, and for monitoring patients who may be at risk.
Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme that helps protect red blood cells from oxidative damage. When individuals with G6PD deficiency are exposed to certain medications, foods, or stressors, their red blood cells cannot adequately defend against oxidative stress, leading to cell membrane damage and hemolysis. Common triggering medications include certain antibiotics, antimalarials, and pain medications.
The information here is for educational purposes only and is not a substitute for professional medical advice. If you suspect drug-induced hemolytic anemia or have been prescribed medications known to trigger hemolysis, consult with a healthcare provider for proper evaluation and testing.